KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:KPC Pharmaceuticals Inc (600422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014119
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xuesaitong Injection, xuesaitong soft capsules, xuesaitong freeze-dried powder for injection, gastrodin capsules, acetagastrodin tablets, gastrodin tablets, colchicines tablet, fibrauretine tablets and injection, and breviscapine tablets, among others. KPC conducts research and development to develop new drugs. The company’s drugs are used for central nervous system disorder, cardiovascular disorders and malaria. It markets its products through its partners across the world. KPC is headquartered in Kunming, China.

KPC Pharmaceuticals Inc (600422) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Rani Therapeutics Raises Funds in Financing 12
Partnerships 14
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
Equity Offering 17
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
Debt Offering 20
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
Acquisition 22
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun’nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc – Key Competitors 30
KPC Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rani Therapeutics Raises Funds in Financing 12
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun'nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc, Key Competitors 30
KPC Pharmaceuticals Inc, Subsidiaries 31
KPC Pharmaceuticals Inc, Joint Venture 31

★海外企業調査レポート[KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AIM Health Group Inc:企業の戦略的SWOT分析
    AIM Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Acciona Energia SA:電力:M&Aディール及び事業提携情報
    Summary Acciona Energy, S.A. (Acciona Energy) formerly Corporacion Energia Hidroelectrica de Navarra, S.A., is a renewable energy company. It owns and operates renewable-based and cogeneration electricity generation assets. The company generates and distributes electricity in Spain. It generates ele …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia Biosciences) is an agricultural and clean technology company that develops and commercializes agricultural products. The company's products exhibit traits include drought tolerance, stacked traits, herbicide tolerance, water use efficiency, nitrogen use effic …
  • Canada Pension Plan Investment Board:企業の戦略・SWOT・財務情報
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Edmond de Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務情報
    Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Xtreme Drilling Corp (XDC):企業の財務・戦略的SWOT分析
    Summary Xtreme Drilling Corp (Xtreme Drilling), formerly Xtreme Drilling and Coil Services Corp is an onshore drilling rig service provider for oil and gas service companies. The company's products include coiled tubing units, drilling rigs, variable frequency drive systems, integrated AC top drives …
  • National Beef Packing Company LLC:企業の戦略・SWOT・財務情報
    National Beef Packing Company LLC - Strategy, SWOT and Corporate Finance Report Summary National Beef Packing Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nishio Rent All Co Ltd (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co Ltd (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Methodist Le Bonheur Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Methodist Le Bonheur Healthcare (Methodist Healthcare) is a healthcare service provider that offers patient care services. The center offers home health services through its hospitals. Its services include invasive spine surgery, education and counseling, cancer treatment and support, infusi …
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務情報
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Olmsted Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes education, neurology, psychia …
  • Evofem Biosciences Inc (EVFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention …
  • Jo-Ann Stores, Inc.:企業の戦略・SWOT・財務情報
    Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Royal Bank of Canada:企業の戦略・SWOT・財務情報
    Royal Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary Royal Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NHPC Ltd (NHPC):電力:M&Aディール及び事業提携情報
    Summary NHPC Ltd (NHPC), a Government of India Enterprise, is an energy utility. It plans, promotes and organizes the development of hydro power plants. The company generates electricity using hydro, wind and solar sources. NHPC’s offerings cover the development operations of conventional and non-co …
  • Showa Shell Sekiyu KK (5002):企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Furukawa Co., Ltd.:企業の戦略・SWOT・財務情報
    Furukawa Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Furukawa Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆